首页> 美国卫生研究院文献>Neoplasia (New York N.Y.) >RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
【2h】

RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation

机译:SMYD2 RB1甲基化通过增加RB1磷酸化增强细胞周期进程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It is well known that RB functions are regulated by posttranslational modifications such as phosphorylation and acetylation, but the significance of lysine methylation on RB has not been fully elucidated. Our expression analysis of SMYD2 by quantitative real-time polymerase chain reaction showed that expression levels of SMYD2 are significantly elevated in human bladder carcinomas compared with nonneoplastic bladder tissues (P < .0001), and its expression levels in tumor tissues were much higher than those of any other normal tissues. SMYD2 knockdown resulted in the suppression of cancer cell growth, and cell cycle analysis indicated that SMYD2 might play a crucial role in the G1/S transition. According to an in vitro methyltransferase assay, we found that SMYD2 methylates RB1 protein, and liquid chromatography-tandem mass spectrometry analysis revealed lysine 810 of RB1 to be methylated by SMYD2. Importantly, this methylation enhanced Ser 807/811 phosphorylation of RB1 both in vitro and in vivo. Furthermore, we demonstrated that methylated RB1 accelerates E2F transcriptional activity and promotes cell cycle progression. SMYD2 is an important oncoprotein in various types of cancer, and SMYD2-dependent RB1 methylation at lysine 810 promotes cell cycle progression of cancer cells. Further study may explore SMYD2-dependent RB1 methylation as a potential therapeutic target in human cancer.
机译:众所周知,RB功能受翻译后修饰如磷酸化和乙酰化的调节,但是赖氨酸甲基化对RB的重要性尚未完全阐明。我们通过定量实时聚合酶链反应对SMYD2的表达分析表明,与非肿瘤性膀胱组织相比,SMYD2在人膀胱癌中的表达水平显着升高(P <.0001),并且在肿瘤组织中的表达水平远高于非肿瘤性膀胱组织。任何其他正常组织。 SMYD2敲低导致癌细胞生长的抑制,并且细胞周期分析表明SMYD2可能在G1 / S过渡中起关键作用。根据体外甲基转移酶测定,我们发现SMYD2使RB1蛋白甲基化,并且液相色谱-串联质谱分析显示RB1的赖氨酸810被SMYD2甲基化。重要的是,这种甲基化在体外和体内均增强了RB1的Ser 807/811磷酸化。此外,我们证明了甲基化的RB1会加速E2F转录活性并促进细胞周期进程。 SMYD2是各种癌症中的重要癌蛋白,赖氨酸810上依赖SMYD2的RB1甲基化促进癌细胞的细胞周期进程。进一步的研究可能探索依赖SMYD2的RB1甲基化作为人类癌症的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号